Peer Review Checklists for Governance


Peer Review Checklists for Governance

Published on 02/12/2025

Peer Review Checklists for Governance in AI/ML Model Validation

The integration of Artificial Intelligence (AI) and Machine Learning (ML) in Good Practice (GxP) analytics presents unique challenges and opportunities in the pharmaceutical industry. This article serves as a comprehensive guide for implementing peer review checklists designed to strengthen governance surrounding AI/ML model validation. By ensuring systematic evaluation through checklists, organizations can confidently address risk, intended use, and data readiness while maintaining compliance with regulatory standards such as FDA, EMA, and MHRA. This guide covers critical aspects, including bias and fairness testing, model verification and validation (V&V), explainability, drift monitoring, as well as documentation practices essential for audit trails.

Understanding the Framework for AI/ML Model Validation

In the context of pharmaceutical applications, AI/ML models must adhere to stringent regulatory frameworks to ensure their safe and effective implementation. This section outlines the fundamental principles behind AI/ML model validation and governance.

Regulatory Expectations

The U.S. FDA has provided guidance regarding the use of AI in medical devices, emphasizing the importance of adequate validation and governance infrastructure. Similarly, the EMA and MHRA have established their expectations through various guidelines, reinforcing the need for compliance with 21 CFR Part 11 and Annex 11. Key considerations include:

  • Risk Management: Proactively identifying and mitigating risks associated with AI/ML applications.
  • Intended Use: Clearly defining the intended purpose of the model is crucial in guiding the validation process.
  • Data Readiness: Ensuring that data used for training, validation, and testing is of high quality, completeness, and relevance.

Important Terminology

Before delving deeper, here’s a brief overview of industry-specific terminology:

  • Explainability (XAI): The ability to explain the reasoning behind AI/ML model predictions.
  • Bias and Fairness Testing: The analysis to ensure that models do not perpetuate or introduce bias.
  • Drift Monitoring: The continuous assessment of model performance over time to detect any deviations in predictive accuracy.

Step 1: Establishing Risk Assessment Frameworks

Risk assessment is a pivotal component in AI/ML model validation. It involves identifying potential risks associated with the model’s intended use and its implementation in pharmaceutical processes.

Risk Identification

The first step involves a thorough analysis of potential risks linked to the model. Considerations should include:

  • Data quality issues which may affect model outcomes.
  • Inaccurate predictions leading to patient safety concerns.
  • Compliance risks arising from insufficient documentation and governance practices.

Risk Evaluation and Prioritization

Once risks are identified, they need to be evaluated and prioritized based on their potential impact and likelihood. Employ tools such as Failure Mode Effects Analysis (FMEA) or Risk Matrices for effective evaluation. Risks can be broadly categorized as:

  • High Risk: Direct implications on patient safety or regulatory compliance.
  • Medium Risk: Potential impact on operational efficiency and compliance.
  • Low Risk: Minimal impact or effects that can be easily mitigated.

Step 2: Ensuring Data Readiness and Curation

Data readiness is critical for effective model performance. Lack of data quality can lead to erroneous predictions and regulatory issues. This step covers data preparation, curation, and readiness assessment.

Data Quality Assessment

Conduct a thorough assessment of the datasets intended for model training and testing. Essential criteria to evaluate include:

  • Completeness: Are there missing data points that need addressing?
  • Accuracy: Is the data pathologically accurate for use in model development?
  • Relevance: Does the dataset adequately represent the population relevant to the intended use?

Data Curation Practices

Implement solid data curation practices to maintain data integrity. This can include:

  • Version control of datasets.
  • Documentation of data sources, cleaning processes, and transformations applied.
  • Establishment of an audit trail for data that reflects all modifications made to the dataset over time.

Step 3: Conducting Bias and Fairness Testing

AI/ML models can unwittingly introduce or reinforce biases present in the training data. Therefore, implementing structured bias and fairness testing is essential.

Framework for Fairness Testing

The testing framework involves the following steps:

  • Defining Fairness Criteria: Establish what fairness means in the context of the model’s intended use.
  • Auditing Model Predictions: Conduct regular audits of model output to identify disproportional impacts across different demographic groups.
  • Mitigation Strategies: Identify and apply techniques to mitigate discovered biases, such as re-weighting datasets or adjusting algorithms.

Inclusive Testing Techniques

Bring diversity into model testing by including demographic representation in test datasets. This will assist in identifying and rectifying potential bias more effectively.

Step 4: Model Verification and Validation (V&V)

Model V&V is the cornerstone of ensuring model performance and compliance with regulatory requirements. This step consists of a rigorous process to confirm that the model performs as intended.

Verification Activities

Verification focuses on whether the model was developed correctly. Key activities include:

  • Code Reviews: Systematic inspections of the code to ensure adherence to best practices.
  • Unit Testing: Testing individual components of the model during development.
  • Integration Testing: Evaluating how various parts of the model work when combined.

Validation Activities

Validation ensures that the model meets performance expectations in real-world scenarios. Important validation checkpoints are:

  • Performance Metrics: Establish acceptable thresholds for accuracy, sensitivity, and specificity.
  • External Validation: Utilize external datasets for validation purposes to ensure robustness.
  • Documentation of Results: Systematically document validation results and any deviations from expected performance.

Step 5: Continuous Monitoring and Drift Re-validation

AI/ML models are not static; they require ongoing monitoring to ensure they maintain performance over time. Boring so-called drift can significantly impact model accuracy. This section describes essential monitoring techniques.

Drift Monitoring Techniques

Monitor your model regularly using the following techniques:

  • Statistical Analysis: Implement statistical tests to compare model performance over time.
  • Visual Analytics: Use dashboards to visualize changes in key performance metrics.
  • Real-time Monitoring: Establishing systems to detect changes as they arise, allowing for immediate corrective measures.

Re-validation Procedures

When signs of drift are detected, appropriate re-validation steps should be initiated including:

  • Reviewing the training dataset for changes that may affect outcomes.
  • Re-training the model with new data to restore accuracy and relevancy.
  • Submitting updated models to the relevant regulatory authorities for re-evaluation where necessary.

Step 6: Documentation and Audit Trails

Robust documentation practices are critical for reproducibility and compliance. Comprehensive organizational documentation should include all aspects of the AI/ML model validation process.

Essential Documentation Components

Maintain detailed documentation encompassing:

  • Validation plans and protocols.
  • Meeting notes from discussions regarding bias testing outcomes.
  • Audit trails illustrating each step of the model’s lifecycle.

Preparing for Audits

Ensure your documentation is readily available for audits. Some best practices include:

  • Organizing files cleanly and logically.
  • Creating a summary repository that outlines critical documentation.
  • Regularly reviewing documentation to ensure it is up to date.

Step 7: Governance Framework for AI/ML

Establishing a robust governance framework is essential for managing the complexities brought forth by AI/ML in GxP contexts. This is vital to ensure compliance, ethical practices, and accountability.

Governance Structure

A proposed governance framework could include:

  • Dedicated AI/ML governance teams tasked with oversight.
  • Regulatory affairs units in contact with governing bodies such as the EMA and MHRA.
  • Regular governance meetings to discuss model performance, compliance, and ethical considerations.

Security Measures

Implement security protocols tailored for AI/ML applications, which could involve:

  • Establishing access controls to sensitive datasets.
  • Regular security audits to detect vulnerabilities.
  • Training staff on data handling requirements as stipulated in 21 CFR Part 11.

Conclusion: Ensuring Robust AI/ML Governance in Pharma

The realization of effective AI/ML model validation in pharmaceutical analytics integrates rigorous frameworks for risk assessment, data readiness, bias and fairness testing, model V&V, drift monitoring, documentation, and governance. Continuous investment in the outlined practices will ultimately enhance both compliance and performance outcomes in line with GAMP 5 guidelines and overarching regulatory expectations.

A vigilant approach to governance and security in AI/ML usage will ensure that pharmaceutical professionals can harness these advanced technologies effectively, providing safe and efficacious solutions that respond to the evolving demands of patient care and regulatory landscapes in the US, UK, and EU.